|
U.S. SEC Fines Deloitte's China Affiliate $20 Million for Auditing Violations
|
09/29/2022
|
Reuters
|
John Mccrank
|
|
Tyson's Choice of CFO Raises Concerns About Potential Conflicts of Interest
|
09/29/2022
|
The Wall Street Journal
|
Jennifer Williams-Alvarez
|
|
Pot Co. Investors Get Judge's Green Light After Past Setbacks
|
09/29/2022
|
Law360 - Securities
|
Sarah Jarvis
|
|
Wall Street's Texting Problem Forces Unhappy Regulators to Send a Billion Dollar Message
|
09/28/2022
|
CNBC
|
Bob Pisani
|
|
Nasdaq Queries SEC Plan on Shareholder Proposal Exclusions
|
09/26/2022
|
Corporate Secretary
|
Ben Maiden
|
|
The Greenwashing Wave Hits Securities Litigation
|
09/22/2022
|
Reuters
|
Roger E. Barton
|
|
SEC Committee Supports, Offers Recommendations on Climate, Cyber Rules
|
09/22/2022
|
Pensions & Investments
|
Courney Degen
|
|
Maxar Technologies Will Pay $27M To Resolve Investor Suit
|
09/21/2022
|
Law360 - Securities
|
Katryna Perera
|
|
Portola Pharma Investors Ink $17.5M Deal Over Stock Declines
|
09/20/2022
|
Law360 - Securities
|
Emilie Ruscoe
|
|
Credit Suisse Settles U.S. Shareholder Lawsuit over Risk Exposure, Archegos
|
09/19/2022
|
Reuters
|
Jonathan Stempel
|
|
New SEC Rule Could Shed Some Light on Executive Pay
|
09/19/2022
|
Pensions & Investments
|
Hazel Bradford
|
|
DOJ to Press Companies to Own Up' for Misconduct, Monaco Says
|
09/16/2022
|
Bloomberg
|
Chris Strohm
|
|
Judge Nixes Lead Plaintiff in Credit Suisse Fraud Case. Are Shareholders Better off?
|
09/15/2022
|
Reuters
|
Alison Frankel
|
|
AstraZeneca Beats U.S. Shareholder Lawsuit over COVID Vaccine Disclosures
|
09/12/2022
|
Reuters
|
Jonathan Stempel
|
|
Crypto Intermediaries Should Register with U.S. SEC, Agency Chair Says
|
09/08/2022
|
Reuters
|
Michelle Price
|
|
SEC Chairman Backs CFTC Getting Some Crypto Authority
|
09/08/2022
|
Pensions & Investments
|
Brian Croce
|
|
Slack Asks Justices To Review 9th Circ.'s Direct Listing Ruling
|
09/07/2022
|
Law360 - Securities
|
Jessica Corso
|
|
U.S. SEC Warns against Switching Auditors to Avoid Chinese Company Trading Bans
|
09/06/2022
|
Reuters
|
Michelle Price
|
|
Geron Investors Ink $24M Deal Over Cancer Study Results
|
09/06/2022
|
Law360 - Securities
|
Donald Morrison
|
|
What to Watch Now in the World of D&O
|
09/05/2022
|
The D&O Diary
|
Kevin LaCroix
|
|
SEC Greenwashing Proposals Don't Find Common Ground
|
09/05/2022
|
Pensions & Investments
|
Brian Croce
|
|
Is the SEC Moving Beyond Disclosure?
|
09/05/2022
|
The Regulatory Review
|
Richard DiNapoli
|
|
S.Africa's Sasol Agrees [to] $24 Mln Settlement in U.S Class Action Suit
|
09/01/2022
|
Reuters
|
Nelson Banya
|
|
Understanding the Impact of the SEC's Amended Proxy Rules
|
08/31/2022
|
Corporate Secretary
|
Sarah Welsh
|
|
5th Circuit Questions Claim that SEC Put Nasdaq on a 'Woke Mission' for Board Diversity
|
08/30/2022
|
Reuters
|
Jody Godoy
|
|
Delisting Risk for U.S.-listed Chinese Stocks Nearly Halves after Regulators Reach Audit Agreement, Goldman Says
|
08/28/2022
|
CNBC
|
Evelyn Cheng
|
|
U.S. and China Reach Landmark Audit Deal in Boon for Chinese Tech Companies
|
08/26/2022
|
Reuters
|
Scott Murdoch, Xie Yu, Samuel Shen, and Michelle Price
|
|
SEC Asks Public for Comment on Draft of New Strategic Plan
|
08/25/2022
|
Pensions & Investments
|
Courtney Degen
|
|
Top Executives Face More Scrutiny Over Pay in New SEC Rule
|
08/25/2022
|
Bloomberg
|
Lydia Beyoud
|
|
Inovio Inks $44M Cash, Stock Deal To End COVID-19 Vax Suit
|
08/23/2022
|
Law360 - Securities
|
Emilie Ruscoe
|
